British drug maker GlaxoSmithKline reports that the Committee for Medicinal Products for Human Use of the European Medicines Agency has given a positive scientific opinion for the company's malaria vaccine Mosquirix.
British drug maker GlaxoSmithKline reports that the Committee for Medicinal Products for Human Use of the European Medicines Agency has given a positive scientific opinion for the company's malaria vaccine Mosquirix.
Share this Article
Recommended